AngioDynamics rises after forecasting smaller loss for 2025
** Shares of medical device maker AngioDynamics ANGO.O
rise 31.6% to $12.37
** ANGO now expects 2025 adj. loss per share between $0.34
and $0.38, down from its prior projection of between $0.38 and
$0.42
** Company continues to expect net sales in the range of
$282 mln to $288 mln
** Posts Q2 net sales of $73 mln, up 9.2%
** Stock had risen ~17% in 2024
(Reporting by Juby Babu in Mexico City)
((Juby.Babu@thomsonreuters.com))
Recent news on AngioDynamics
See all newsAngioDynamics, Inc. reports results for the quarter ended August 31 - Earnings Summary
AngioDynamics Q1 sales beat on med tech segment growth
AngioDynamics, Inc. expected to post a loss of 11 cents a share - Earnings Preview
AngioDynamics, Inc. expected to post a loss of 11 cents a share - Earnings Preview
AngioDynamics Inc reports results for the quarter ended May 31 - Earnings Summary